Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Cash Flow from Others: $222 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JCARE Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
74 GF Score
Price $8.00
GF Value $9.37
! 3 Warning Signs
View Full Analysis

What is Joincare Pharmaceutical Group Industry Co Cash Flow from Others?

Joincare Pharmaceutical Group Industry Co XSWX:JCARE 74 Cash Flow from Others is $222 Mil as of Jun. 2026. GuruFocus rates XSWX:JCARE with a GF Score™ of 74/100 and a GF Value™ of $9.37. The stock has 3 warning signs investors should review.

Joincare Pharmaceutical Group Industry Co's cash flow from others for the three months ended in Jun. 2026 was $95 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2026 was $222 Mil.

Joincare Pharmaceutical Group Industry Co Cash Flow from Others Related Terms

Joincare Pharmaceutical Group Industry Co Cash Flow from Others Historical Data

* Premium members only.

The historical data trend for Joincare Pharmaceutical Group Industry Co's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joincare Pharmaceutical Group Industry Co Cash Flow from Others Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.61 46.20 75.29 48.28 44.33

Joincare Pharmaceutical Group Industry Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.71 55.34 66.73 4.53 95.20
XSWX:JCARE
74GF Score
Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
Cash Flow from Others is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Joincare Pharmaceutical Group Industry Co Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $222 Mil.

Frequently Asked Questions Learn more about Cash Flow from Others →
What does a Cash Flow from Others of $222 Mil mean?
Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) has a Cash Flow from Others of $222 Mil as of Jun. 2026. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Joincare Pharmaceutical Group Industry Co and its competitors.
Is Joincare Pharmaceutical Group Industry Co's Cash Flow from Others too high?
Joincare Pharmaceutical Group Industry Co's current Cash Flow from Others is $222 Mil. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Cash Flow from Others compare to ZTS?
Joincare Pharmaceutical Group Industry Co's Cash Flow from Others of $222 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Others for a Drug Manufacturers company?
A good Cash Flow from Others depends on the Drug Manufacturers industry context. However, Cash Flow from Others should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Others mean?
A high Cash Flow from Others can signal that a stock is expensive relative to its fundamentals. Cash Flow from Others is the amount of cash earned or paid from other, nonstandard operations. View historical data for Joincare Pharmaceutical Group Industry Co and its competitors. Joincare Pharmaceutical Group Industry Co's current Cash Flow from Others is $222 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) has a current Cash Flow from Others of $222 Mil. The stock's GF Value™ is $9.37, compared to a current price of $8.00 — trading 14.6% below its estimated fair value. The current Cash Flow from Others is $222 Mil. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 74/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Others calculated?
Cash Flow from Others is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (XSWX:JCARE), the current Cash Flow from Others is $222 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Overvalued in 2026?

Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued. The current stock price of $8.00 is trading 14.6% below its estimated GF Value™ of $9.37.

Key valuation signals for XSWX:JCARE:

  • Cash Flow from Others: $222 Mil
  • GF Value™: $9.37 vs. price of $8.00 (14.6% below fair value)
  • GF Score™: 74/100 with 3 warning signs

No single metric tells the full story. See the XSWX:JCARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Joincare Pharmaceutical Group Industry Co Business Description

Other Exchanges 600380:China
Address No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
74GF Score

Get the complete analysis for XSWX:JCARE

Cash Flow from Others is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$9.37
GF Value